AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimtoss 3mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Astonea Labs Private Limited

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Glimtoss 3mg/500mg Tablet

Diabetace 3mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabetace 3mg/500mg tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating a balanced diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Consistent meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended by your doctor.

Uses of Glimtoss 3mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimtoss 3mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Glimtoss 3mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glimtoss 3mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimtoss 3mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimtoss 3mg/500mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

How Glimtoss 3mg/500mg Tablet works:

Glimepiride/Metformin 3mg/500mg tablets (Glimtoss) combine two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glimtoss 3mg/500mg Tablet ingestion poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimtoss 3mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The medication Glimtoss, 3mg/500mg tablets, is contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this drug.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimtoss 3mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glimtoss 3mg/500mg tablet use. Consult a physician. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimtoss 3mg/500mg tablets cautiously, potentially requiring dose modification. A physician's consultation is recommended. For individuals with mild to moderate liver disease, initiation with a low Glimtoss 3mg/500mg tablet dosage is typical; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimtoss 3mg/500mg Tablet :

Should you forget a Glimtoss 3mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimtoss 3mg/500mg Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Glimtoss 3mg/500mg Tablet

Store this medication in its original, tightly sealed container. Follow the storage instructions provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Glimtoss 3mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in individuals with kidney impairment, the elderly, or those who consume substantial alcohol. Symptoms such as muscle aches, weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal pain, or bradycardia warrant immediate discontinuation of Glimtoss 3mg/500mg Tablets and prompt medical attention.
The combined medication Glimtoss, containing 3mg of Glimepiride and 500mg of Metformin, manages type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when coupled with a balanced diet and regular physical activity. Glimepiride stimulates insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Taking Glimtoss 3mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), changes in taste perception, nausea, abdominal discomfort, loose stools, and headaches. Rare but potentially serious adverse reactions include lactic acidosis. Prolonged treatment may result in vitamin B12 deficiency.
Prolonged Glimtoss 3mg/500mg Tablet use can indeed lead to Vitamin B12 deficiency. This medication impairs the body's absorption of Vitamin B12 within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Preventive measures, recommended by some studies, include supplemental Vitamin B12 at least annually.
Indeed, Glimtoss 3mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Readily available glucose sources, such as glucose tablets, honey, or fruit juice, should always be kept on hand.
Combining Glimtoss 3mg/500mg tablets and alcohol is unsafe. This combination can dangerously reduce blood sugar, potentially causing hypoglycemia, and raises the risk of lactic acidosis.
Glimtoss 3mg/500mg Tablet
74
MRP 90
17% off